Skip to content

European Carto® XP REgistry for Validating Specialized CFAE SOftware

EXPRESSO - European Carto® XP REgistry for Validating Specialized CFAE SOftware

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00812916
Acronym
EXPRESSO
Enrollment
206
Registered
2008-12-22
Start date
2008-09-30
Completion date
2010-12-31
Last updated
2016-02-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation

Keywords

Persistent or longstanding persistent atrial fibrillation

Brief summary

The purpose of this prospective observational study (registry) is to determine the acute success rate of a complex fractionated atrial electrogram (CFAE) guided ablation procedure using a dedicated software and to determine the functionality and performance of the CFAE software in patients with a type of persistent atrial fibrillation (AF) in routine clinical practice.

Detailed description

This was a prospective, multi-center, observational registry study evaluating CARTO® XP CFAE Software (CFAE Software) in subjects with chronic AF requiring CFAE-guided RFCA. Use of the CARTO® 3 System (including CFAE Software) was also allowed. The primary efficacy endpoint was the acute success rate of CFAE-guided radiofrequency catheter ablation (RFCA) using the CFAE Software. Acute success is defined as the subject achieving sinus rhythm at the end of the procedure without electrical or pharmaceutical cardioversion. Secondary endpoints consisted of measures of efficacy (example, performance of the CFAE Software) and of safety (example, number of procedure-related adverse events).

Interventions

PROCEDURERF ablation, using specialized CFAE software

RF ablation

Sponsors

Biosense Webster EMEA
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Persistent or longstanding persistent AF

Exclusion criteria

* Previously underwent RF ablation for AF and patients with paroxysmal AF

Design outcomes

Primary

MeasureTime frameDescription
Acute SuccessEnd of procedureSinus rhythm achieved at end of ablation procedure without electrical or pharmaceutical cardioversion

Secondary

MeasureTime frameDescription
Total Ablation TimeProceduralTotal time of ablation with exception of 10 outliers with \>180 minutes of total ablation time reported
Total Complex Fractionated Atrial Electrogram (CFAE) Mapping TimeProceduralTotal of left and right atrium CFAE mapping times with exception of 9 outliers reporting total CFAE mapping time of \>120 minutes
Total Radiofrequency (RF) DurationProceduralTotal duration of all radiofrequency applications with exception of 12 outliers recording \>150 minutes.
Total Fluoroscopy TimeProceduralMean total fluoroscopy time
Total Number of Ablated Complex Fractionated Atrial Electrogram (CFAE) Discrete PointsProceduralDoes not include 2 outliers with \>300 CFAE discrete points. Based on the user-defined definition of a CFAE complex, the system identifies the number of intervals between adjacent CFAE complexes and the cycle length of these intervals. This makes it possible to estimate the number of CFAE complexes within certain amplitude and duration values. A CFAE complex is defined by the system based on the intervals between the peaks. Therefore, clinically, the CFAE software includes an algorithm that enables detection of CFAE complexes. The automatic detection and distribution of CFAE signals is taking place during a 2.5 second intra-cardiac ECG recording. When the CFAE areas are completely eliminated, but the arrhythmia continues as organized atrial flutter or atrial tachycardia, the atrial tachy-arrhythmias may be mapped and ablated upon discretion of the investigator. Analyses occur post-procedure.

Countries

France, Germany, Hungary

Participant flow

Participants by arm

ArmCount
Radiofrequency (RF) Ablation
RF Ablation using specialized complex fractionated atrial electrogram (CFAE) software
206
Total206

Baseline characteristics

CharacteristicRadiofrequency (RF) Ablation
Age, Customized
Not Collected
206 participants
Sex/Gender, Customized
Not Collected
206 participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
3 / 205
serious
Total, serious adverse events
13 / 205

Outcome results

Primary

Acute Success

Sinus rhythm achieved at end of ablation procedure without electrical or pharmaceutical cardioversion

Time frame: End of procedure

Population: Patients with CFAE-guided RF catheter ablation

ArmMeasureValue (NUMBER)
Radiofrequency (RF) AblationAcute Success48.8 percentage achieving success
Secondary

Total Ablation Time

Total time of ablation with exception of 10 outliers with \>180 minutes of total ablation time reported

Time frame: Procedural

Population: Safety population with ablation time reported

ArmMeasureValue (MEAN)Dispersion
Radiofrequency (RF) AblationTotal Ablation Time61.4 minutesStandard Deviation 42
Secondary

Total Complex Fractionated Atrial Electrogram (CFAE) Mapping Time

Total of left and right atrium CFAE mapping times with exception of 9 outliers reporting total CFAE mapping time of \>120 minutes

Time frame: Procedural

Population: Safety population with mapping time reported

ArmMeasureValue (MEAN)Dispersion
Radiofrequency (RF) AblationTotal Complex Fractionated Atrial Electrogram (CFAE) Mapping Time27.7 minutesStandard Deviation 15.4
Secondary

Total Fluoroscopy Time

Mean total fluoroscopy time

Time frame: Procedural

Population: Safety population with fluoroscopy time reported

ArmMeasureValue (MEAN)Dispersion
Radiofrequency (RF) AblationTotal Fluoroscopy Time43.3 minutesStandard Deviation 28.6
Secondary

Total Number of Ablated Complex Fractionated Atrial Electrogram (CFAE) Discrete Points

Does not include 2 outliers with \>300 CFAE discrete points. Based on the user-defined definition of a CFAE complex, the system identifies the number of intervals between adjacent CFAE complexes and the cycle length of these intervals. This makes it possible to estimate the number of CFAE complexes within certain amplitude and duration values. A CFAE complex is defined by the system based on the intervals between the peaks. Therefore, clinically, the CFAE software includes an algorithm that enables detection of CFAE complexes. The automatic detection and distribution of CFAE signals is taking place during a 2.5 second intra-cardiac ECG recording. When the CFAE areas are completely eliminated, but the arrhythmia continues as organized atrial flutter or atrial tachycardia, the atrial tachy-arrhythmias may be mapped and ablated upon discretion of the investigator. Analyses occur post-procedure.

Time frame: Procedural

Population: Safety population with non-outlier endpoint reported

ArmMeasureValue (MEAN)Dispersion
Radiofrequency (RF) AblationTotal Number of Ablated Complex Fractionated Atrial Electrogram (CFAE) Discrete Points33.5 pointsStandard Deviation 43.1
Secondary

Total Radiofrequency (RF) Duration

Total duration of all radiofrequency applications with exception of 12 outliers recording \>150 minutes.

Time frame: Procedural

Population: Safety population with RF data reported

ArmMeasureValue (MEAN)Dispersion
Radiofrequency (RF) AblationTotal Radiofrequency (RF) Duration76.2 minutesStandard Deviation 24.8

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026